Advertisement
UK markets closed
  • FTSE 100

    8,433.76
    +52.41 (+0.63%)
     
  • FTSE 250

    20,645.38
    +114.08 (+0.56%)
     
  • AIM

    789.87
    +6.17 (+0.79%)
     
  • GBP/EUR

    1.1622
    +0.0011 (+0.09%)
     
  • GBP/USD

    1.2525
    +0.0001 (+0.01%)
     
  • Bitcoin GBP

    48,605.32
    -1,623.32 (-3.23%)
     
  • CMC Crypto 200

    1,265.12
    -92.88 (-6.84%)
     
  • S&P 500

    5,222.68
    +8.60 (+0.16%)
     
  • DOW

    39,512.84
    +125.08 (+0.32%)
     
  • CRUDE OIL

    78.20
    -1.06 (-1.34%)
     
  • GOLD FUTURES

    2,366.90
    +26.60 (+1.14%)
     
  • NIKKEI 225

    38,229.11
    +155.13 (+0.41%)
     
  • HANG SENG

    18,963.68
    +425.87 (+2.30%)
     
  • DAX

    18,772.85
    +86.25 (+0.46%)
     
  • CAC 40

    8,219.14
    +31.49 (+0.38%)
     

Coronavirus vaccine is only thing that could keep bull market alive: veteran trader

The raging Wall Street bull would also like its coronavirus vaccine, and quickly.

“For traders, this is the unknown unknown. I think you definitely could see another shoe drop,” veteran trader Alan Valdes of Silverbear Capital said of the current market volatility on Yahoo Finance’s The First Trade. Valdes suggested traders would like to see a coronavirus vaccine before more aggressively moving back into stocks and taking a pause in driving up market volatility.

“That [a vaccine] could be a year and a half away. I don’t think we will have these crazy fluctuations for a year and a half, but this market is not really going to stabilize,” Valdes said. To Valdes’ point, only drumaker Gilead has shown strong progress on getting a coronavirus vaccine to market before the summer. The company’s remdesivir is currently in Phase 3 testing to treat coronavirus.

In the meantime, volatility in markets looks to be the name of the game for the foreseeable future. That’s despite the Federal Reserve’s 50 basis emergency rate cut earlier this week meant to tamp down coronavirus concerns on the Street. If anything, sources have told Yahoo Finance, the cut — and another 25 basis point cut when the Fed meets in two weeks — signal a U.S. economy that has felt a sharp growth slowdown.

Nicholas Brigandi, right, managing director of NYSE floor operations, works with traders at the post that handles Enservco Corp., on the floor of the New York Stock Exchange, Friday, June 20, 2014. Stocks held on to small gains, enough to mark the latest record high closes for major indexes. (AP Photo/Richard Drew)
(AP Photo/Richard Drew)

The S&P 500, Dow Jones Industrial Average and Nasdaq Composite were each off by more than 2% on Thursday, indicating equities would give back a big chunk of gains after Wednesday’s surge. A still-escalating coronavirus outbreak around the world continued to weigh heavily on the minds of investors.

ADVERTISEMENT

“With sentiment, not macro variables, driving volatility and quants enhancing the move, expect volatile markets as this debate intensifies. Large virus clusters showing up in the U.S. would go a long way in settling the debate,” cautioned Evercore ISI strategist Dennis DeBusschere. “We lean bullish given the solid consumer backdrop, high implied volatility and aggressive easing, but an extended rally is unlikely until investors have comfort that a consumer retrenchment is unlikely.”

Brian Sozzi is an editor-at-large and co-anchor of The First Trade at Yahoo Finance. Follow Sozzi on Twitter @BrianSozzi and on LinkedIn.

Read the latest financial and business news from Yahoo Finance

Follow Yahoo Finance on Twitter, Facebook, Instagram, Flipboard, SmartNews, LinkedIn, YouTube, and reddit.